Welcome to Shanghai KASONS Technology Co., Ltd.
Back to resources
Product Updates

UDP-Galactosamine and UDP-GalNAc in Glycobiology Research

UDP-Galactosamine and UDP-GalNAc in Glycobiology Research

Activated UDP sugars are used to study how enzymes assemble glycans and to explore glycoengineering approaches for antibodies, enzymes, and vaccines.

Activated UDP sugars are used to study how enzymes assemble glycans and to explore glycoengineering approaches for antibodies, enzymes, and vaccines.

Chemical information

The source identifies the compound as uridine 5′-diphosphate 2-amino-2-deoxy-D-galactose disodium salt and lists CAS 17479-06-0, molecular formula C15H25N3O16P2, and molecular weight 565.32 g/mol. It also refers to UDP-GalNAc in its applications. UDP-galactosamine and UDP-N-acetylgalactosamine (UDP-GalNAc) are chemically distinct; confirm the precise identity and salt form against the product specification before use.

Structural features

UDP activates the sugar for transfer and acts as the leaving group. Glycosyltransferases select particular donors and transfer the sugar to acceptors on glycans, proteins, or lipids. The C2 substitution distinguishes galactosamine-based donors from UDP-galactose and affects enzyme recognition. These differences matter when studying glycosaminoglycans and other glycans involved in molecular recognition and signaling.

Applications

Glycoengineering and vaccines

With a compatible transferase and donor, researchers can explore installing sugars at selected sites on proteins or antibodies and study the effects on half-life, targeting, and immunogenicity. Defined nucleotide sugars can also support synthesis of pathogen-associated glycan antigens for glycoconjugate vaccine research.

Enzymology and O-glycosylation

UDP-GalNAc is used to study GalNAc-transferase kinetics, substrate specificity, and cellular function. These enzymes initiate mucin-type O-glycosylation. In vitro and in vivo experiments can help clarify the role of O-glycosylation in cell communication, cancer progression, and immune responses.

Diagnostics and biomarkers

Cell-surface glycan profiles can change in disease. UDP-GalNAc and suitable derivatives are tools for studying GalNAc-transferase activity and abnormal O-glycosylation patterns as potential biomarker leads.

Conclusion

Choosing the correct nucleotide sugar donor is essential to using these tools effectively in glycan biosynthesis and glycoengineering experiments.

UDP-Galactosamine and UDP-GalNAc in Glycobiology Research